Table 1
| SWOG/ Support |
STUDY | R E G |
O P E N |
ARM | ACCR. GOAL |
TOTAL REGS. |
REGS. LAST 12 Month |
REGS. LAST 6 Month |
REGS. LAST 3 Month |
REGS. LAST 30 DAYS |
REGS. LAST 7 DAYS |
DATE OF FIRST REG. |
# of ACT. INSTs |
# of CURR IRBs |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SWOG | S1608-FL, TGR-1202/Lenalidomide/CHOP or Benda +Ob | 1 | T | 1 TGR-1202 + Obinutuzumab | 150 | 12 | 10 | 6 | 4 | 1 | 0 | 01/23/2018 | 267 | 98 |
| 2 Lenalidomide + Obinutuzumab | 12 | 10 | 6 | 4 | 2 | 0 | ||||||||
| 3 CHOP + Obinutuzumab | 7 | 4 | 2 | 1 | 1 | 0 | ||||||||
| 4 Bendamustine + Obinutuzumab | 6 | 6 | 2 | 0 | 0 | 0 | ||||||||
| 37 | 30 | 16 | 9 | 4 | 0 | |||||||||
| S1826-HD, Adv, Age 12+, N+AVD vs BV+AVD | 1 | Y | 1 Nivolumab + AVD | 987 | 6 | 6 | 6 | 6 | 5 | 2 | 08/29/2019 | 153 | 60 | |
| 2 Brentuximab Vedotin + AVD | 6 | 6 | 6 | 6 | 4 | 1 | ||||||||
| 12 | 12 | 12 | 12 | 9 | 3 | |||||||||
| Yes | E4412-HD, RR, Ipilimumab +Nivo +Brentuximab Vedotin | 1 | E | Total Registrations | 4 | 4 | 4 | 0 | 0 | 0 | 04/17/2019 | 127 | 53 | |
| 4 | 4 | 4 | 0 | 0 | 0 | |||||||||
| EA4151-Lymph, AHCT +/-Ritux, MRD Neg | 0 | E | Total Registrations | 39 | 28 | 15 | 11 | 3 | 1 | 04/03/2018 | 161 | 72 | ||
| 39 | 28 | 15 | 11 | 3 | 1 | |||||||||
| 1 | E | Total Registrations | 25 | 18 | 10 | 4 | 2 | 0 | 04/03/2018 | |||||
| 25 | 18 | 10 | 4 | 2 | 0 | |||||||||